William Link

Bill Link is a leader in the healthcare industry. He is a Managing Director of Versant Ventures, a leading venture capital firm focused in healthcare. At Versant, Bill has specialized in early-stage investing in medical devices. Prior to co-founding Versant Ventures in 1999, Bill was a general partner at Brentwood Venture Capital. With more than two decades of operations experience in the healthcare industry, he has a proven record of building and managing large, successful medical product companies.

Prior to entering venture capital, Bill founded two companies which still today are leaders in the field of surgical ophthalmology. In 1987 Bill founded, and served as chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products. Chiron Vision was sold to Bausch and Lomb in 1997. Prior to Chiron Vision, Bill founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986. Later Bill served on the Board of AMO’s successor company, Advanced Medical Optics (AMO) which was acquired by Abbott in 2009. Bill serves on the Board of several private companies and is on the Board of three public companies, Glaukos (GKOS), Second Sight (EYES) and Edwards Life Sciences (EW).

Before entering the healthcare industry, Bill was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine. Bill received his BS, MS and PhD in Mechanical Engineering from Purdue University.